TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35469777

Group type: EXPERIMENTAL
Intervention: Outreach Contact plus Decision Counseling (OC-DC)
Number of subjects: 2376

Group type: EXPERIMENTAL
Intervention: Outreach Contact alone (OC)
Number of subjects: 2376

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2376
Study: 33843315

Group type: EXPERIMENTAL
Intervention: Promotion of healthy food choices
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Raising awareness of negative health consequences of excessive consumption of sugar, fat, and sodium
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Promotion of informed food choices
Number of subjects: 774
Study: 32573474

Group type: EXPERIMENTAL
Intervention: Conventional flap surgery with PRF
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional flap surgery (Control)
Number of subjects: 60
Study: 36231494

Group type: EXPERIMENTAL
Intervention: ELLA training for the promotion of emotional and social competences
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 140
Study: 32871952

Group type: EXPERIMENTAL
Intervention: miRNA-146b-3p
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: miRNA-363–3p
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Risk score based on miRNA-146b-3p and miRNA-363–3p
Number of subjects: 506
Study: 35040506

Group type: EXPERIMENTAL
Intervention: Sirolimus (2-6 mg daily) for 48 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32131912

Group type: EXPERIMENTAL
Intervention: ZuraGard, a 2% chlorhexidine/70% isopropyl alcohol preparation
Number of subjects: 3277

Group type: COMPARATOR
Intervention: Chloraprep (control)
Number of subjects: 3277

Group type: EXPERIMENTAL
Intervention: ZuraGard
Number of subjects: 3277

Group type: COMPARATOR
Intervention: Chloraprep
Number of subjects: 3277
Study: 35977053

Group type: EXPERIMENTAL
Intervention: ROTEM-guided transfusion strategy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional transfusion strategy
Number of subjects: 60
Study: 32925421

Group type: EXPERIMENTAL
Intervention: Multimedia-based patient counseling (video education)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Traditional conversation-based patient counseling (control group)
Number of subjects: 98
Study: 35882375

Group type: EXPERIMENTAL
Intervention: Oral carbohydrate (OC group) - 300 mL/bottle
Number of subjects: 112

Group type: COMPARATOR
Intervention: Oral placebo (OP group) - 300 mL distilled water
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (C group) - forbidden from drinking or eating
Number of subjects: 112
Study: 34854808

Group type: EXPERIMENTAL
Intervention: Primary trabeculectomy treatment - trabeculectomy augmented with mitomycin C
Number of subjects: 453

Group type: COMPARATOR
Intervention: Primary medical treatment - escalating medical management with glaucoma eye drops
Number of subjects: 453
Study: 33274689

Group type: EXPERIMENTAL
Intervention: Tirofiban combined with heparin
Number of subjects: 98

Group type: COMPARATOR
Intervention: Aspirin + clopidogrel
Number of subjects: 98
Study: 33049730

Group type: EXPERIMENTAL
Intervention: 100% oxygen at 10 l/min until delivery
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional care without additional oxygen
Number of subjects: 117
Study: 35068016

Group type: EXPERIMENTAL
Intervention: Shaker head-lift exercise (HLE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard dysphagia management (control)
Number of subjects: 52
Study: 34687435

Group type: EXPERIMENTAL
Intervention: Copaiba oil in silicone gel, applied twice a day for 84 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo gel, applied twice a day for 84 days
Number of subjects: 42
Study: 32632523

Group type: EXPERIMENTAL
Intervention: surgical mask (sm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FFP2/N95 mask (ffpm)
Number of subjects: 12

Group type: COMPARATOR
Intervention: no mask (nm)
Number of subjects: 12
Study: 36160864

Group type: EXPERIMENTAL
Intervention: Acetazolamide (375 mg/d)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 33576219

Group type: EXPERIMENTAL
Intervention: Curcumin gel (Curenext)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aloe Vera gel (Aloe Vera 100% relief)
Number of subjects: 60
Study: 35248428

Group type: EXPERIMENTAL
Intervention: Meek technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: meshed group
Number of subjects: 40
Study: 33589582

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Blood pressure management
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cholesterol management
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Overall therapeutic objectives
Number of subjects: 200
Study: 36125473

Group type: EXPERIMENTAL
Intervention: Helmet noninvasive ventilation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual respiratory support
Number of subjects: 320
Study: 33550706

Group type: COMPARATOR
Intervention: AHA diet
Number of subjects: 98

Group type: COMPARATOR
Intervention: FLiO diet
Number of subjects: 98
Study: 32166308

Group type: EXPERIMENTAL
Intervention: Bevacizumab + vorinostat
Number of subjects: 90

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 90
Study: 35717193

Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (MDA) with efficient duration of delivery (within ten days)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Various combinations of influential intervention components
Number of subjects: 360

Group type: COMPARATOR
Intervention: No individual activity
Number of subjects: 360
Study: 34914243

Group type: EXPERIMENTAL
Intervention: Hydromorphone (HM)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-dose dexmedetomidine + Hydromorphone (DM + HM)
Number of subjects: 102
Study: 35961520

Group type: EXPERIMENTAL
Intervention: Durvalumab (1500 mg intravenously) every 4 weeks for up to 24 months
Number of subjects: 117
Study: 34788640

Group type: EXPERIMENTAL
Intervention: Posterior left pericardiotomy
Number of subjects: 420

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 420
Study: 35290183

Group type: EXPERIMENTAL
Intervention: Exo4Work exoskeleton
Number of subjects: 22
Study: 32621383

Group type: EXPERIMENTAL
Intervention: Severe acne patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 51
Study: 36042582

Group type: EXPERIMENTAL
Intervention: Low-frequency electric pulse therapy (LFEPT) combined with tropisetron hydrochloride and dexamethasone hydrochloride
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group with tropisetron hydrochloride and dexamethasone hydrochloride
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Low-frequency electric pulse therapy (LFEPT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 33417292

Group type: EXPERIMENTAL
Intervention: Henagliflozin 5 mg
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 34850605

Group type: EXPERIMENTAL
Intervention: Abdominal massage before gavage feeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no abdominal massage)
Number of subjects: 120
Study: 34518147

Group type: COMPARATOR
Intervention: Water-based circuit training exercise (WEX)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gym-based circuit training exercise (GEX)
Number of subjects: 52
Study: 35220359

Group type: EXPERIMENTAL
Intervention: ECT plus agomelatine 50 mg/d
Number of subjects: 97

Group type: COMPARATOR
Intervention: ECT plus placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Agomelatine 50 mg/d during follow-up
Number of subjects: 97
Study: 33405474

Group type: EXPERIMENTAL
Intervention: Mechanical Advantage Tourniquet (MAT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Combat Application Tourniquet (CAT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Stretch Wrap and Tuck Tourniquet (SWATT)
Number of subjects: 96
Study: 35030239

Group type: EXPERIMENTAL
Intervention: Serum caffeine (T3 compared with T1)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Paraxanthine (T3 compared with T1)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Theobromine (T3 compared with T1)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Total caffeinated beverages (>3 compared with 0 servings/d)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (>2 compared with 0 servings/d)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Caffeinated soda (>2 servings/d)
Number of subjects: 1228
Study: 32371166

Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT) during the third trimester
Number of subjects: 0
Study: 34018430

Group type: EXPERIMENTAL
Intervention: Condensed (2 hours) version of a popular Swahili radio drama
Number of subjects: 1200
Study: 35179082

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Therapy
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Short-Term Psychoanalytic Psychotherapy
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Brief Psychosocial Intervention
Number of subjects: 465

Group type: COMPARATOR
Intervention: Control Group (not specified)
Number of subjects: 465
Study: 36410223

Group type: EXPERIMENTAL
Intervention: Bupropion 75 mg twice daily for twelve weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 33406087

Group type: EXPERIMENTAL
Intervention: Musculoskeletal impairment (MSI)
Number of subjects: 8801

Group type: COMPARATOR
Intervention: No formal education
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Congenital causes of MSI
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Neurological causes of MSI
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Acquired non-traumatic non-infective causes of MSI
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Trauma-related causes of MSI
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Infection-related causes of MSI
Number of subjects: 8801

Group type: EXPERIMENTAL
Intervention: Quality of life measures using EQ-5D
Number of subjects: 8801
Study: 32080103

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation therapy with active electrical stimulation
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation therapy
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active electrical stimulation
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: All groups (including placebo)
Number of subjects: 144
Study: 36660969

Group type: EXPERIMENTAL
Intervention: Exergaming 3 days a week for 6 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vestibular training 3 days a week for 6 weeks
Number of subjects: 24
Study: 34188459

Group type: EXPERIMENTAL
Intervention: ICT-based multicomponent program applied twice per week, once per day for 12 weeks, 30 min per session
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual daily activities (control group)
Number of subjects: 20
Study: 32274890

Group type: EXPERIMENTAL
Intervention: iButton data logger system
Number of subjects: 25

Group type: COMPARATOR
Intervention: Infrared pistol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Skin's perfusion of microcirculation
Number of subjects: 25
Study: 36462798

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 50
Study: 32987492

Group type: EXPERIMENTAL
Intervention: Pectoral (PEC II) block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Serratus-intercostal fascial plane (SIFP) block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 60
Study: 34590538

Group type: EXPERIMENTAL
Intervention: Condom Use Self-Efficacy Scale (CUSES)
Number of subjects: 79
Study: 34581237

Group type: EXPERIMENTAL
Intervention: Spontaneous pushing with pursed lips breathing
Number of subjects: 62

Group type: COMPARATOR
Intervention: Directed pushing associated with Valsalva Manoeuvre (VM)
Number of subjects: 62
Study: 34029678

Group type: EXPERIMENTAL
Intervention: Non-regulated interventions
Number of subjects: 549

Group type: COMPARATOR
Intervention: Regulated interventions
Number of subjects: 549
Study: 35044883

Group type: EXPERIMENTAL
Intervention: PALliatiVE approach (Prepare, Ask, Listen, Validate, Consult an Expert)
Number of subjects: 0
Study: 32633217

Group type: EXPERIMENTAL
Intervention: Evening (PM; 16:00 hr)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Preferred time (PREF)
Number of subjects: 12
Study: 36442484

Group type: EXPERIMENTAL
Intervention: Rezafungin (400 mg in week 1, followed by 200 mg weekly, for a total of two to four doses)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Caspofungin (70 mg loading dose on day 1, followed by 50 mg daily)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Rezafungin
Number of subjects: 199

Group type: COMPARATOR
Intervention: Caspofungin
Number of subjects: 199
Study: 33838756

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 vaccine (low dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 vaccine (high dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo or alternative treatment not specified)
Number of subjects: 0
Study: 35880264

Group type: EXPERIMENTAL
Intervention: Supervised functional level‐based exercise program (40 min, 5 times a week during hospitalization)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Unsupervised functional level‐based exercise program
Number of subjects: 124
Study: 34489928

Group type: EXPERIMENTAL
Intervention: Autologous dendritic cells (DCs) administered in combination with neoadjuvant chemotherapy (NAC-AC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NAC-AC) without DCs (control group)
Number of subjects: 20
Study: 36107991

Group type: EXPERIMENTAL
Intervention: High-resistance inspiratory muscle strength training (75% PIMAX)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Low-resistance sham training (15% PIMAX)
Number of subjects: 128
Study: 34801061

Group type: EXPERIMENTAL
Intervention: SMART program (self-management intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 33404004

Group type: EXPERIMENTAL
Intervention: Mandrax use
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Other substance use (heavy drinking, marijuana, methamphetamine)
Number of subjects: 500
Study: 35807836

Group type: EXPERIMENTAL
Intervention: C. rabens extract capsule
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32352676

Group type: EXPERIMENTAL
Intervention: Contractubex gel applied 3 times a day for 9 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: No regular therapy (control group)
Number of subjects: 60
Study: 35129111

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 32883514

Group type: EXPERIMENTAL
Intervention: High antimüllerian hormone (AMH) levels in women with PCOS
Number of subjects: 264

Group type: COMPARATOR
Intervention: Unexplained infertility cohort
Number of subjects: 264
Study: 32446208

Group type: EXPERIMENTAL
Intervention: Hyperventilation (HV) in sitting position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyperventilation (HV) in supine position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyperventilation (HV) in supine position (younger age group 4-7 years)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyperventilation (HV) in sitting position (younger age group 4-7 years)
Number of subjects: 20
Study: 36180156

Group type: EXPERIMENTAL
Intervention: Hold-relax PNF
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Unilateral lumbar mobilization (LM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 34560705

Group type: EXPERIMENTAL
Intervention: Positive psychological intervention + care as usual
Number of subjects: 68

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 68
Study: 36193181

Group type: EXPERIMENTAL
Intervention: DEX + LIDO
Number of subjects: 26

Group type: COMPARATOR
Intervention: LIDO alone
Number of subjects: 26
Study: 33494045

Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s) during jump landing
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s) during dominant leg cutting
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s)
Number of subjects: 41
Study: 33852258

Group type: EXPERIMENTAL
Intervention: Ceramide-containing sunscreen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceramide-containing moisturizing cream
Number of subjects: 0
Study: 33059610

Group type: EXPERIMENTAL
Intervention: Multicomponent non-pharmacological intervention (MAKS-s)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Care as usual (waitlist control group)
Number of subjects: 144
Study: 36188642

Group type: EXPERIMENTAL
Intervention: Alvogyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cutanplast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34418987

Group type: EXPERIMENTAL
Intervention: Brief text messaging intervention (StAR2D)
Number of subjects: 0
Study: 32835925

Group type: EXPERIMENTAL
Intervention: donepezil (10 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 36198467

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: RT combined with balance training
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group with usual daily activities
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: All groups (RT, RT with balance training, Control)
Number of subjects: 66
Study: 34530759

Group type: EXPERIMENTAL
Intervention: CA125
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: HE4
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: OPN
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: leptin
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: prolactin
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Logistical regression model (CA125, HE4, OPN, leptin, prolactin)
Number of subjects: 43
Study: 32387067

Group type: EXPERIMENTAL
Intervention: Prior myocardial infarction (MI)
Number of subjects: 8916

Group type: EXPERIMENTAL
Intervention: Post-enrollment myocardial infarction (MI)
Number of subjects: 8916
Study: 37127433

Group type: EXPERIMENTAL
Intervention: 5000 ppm fluoride toothpaste
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1450 ppm fluoride toothpaste
Number of subjects: 24
Study: 33651633

Group type: EXPERIMENTAL
Intervention: Dynamic Resistance Training (DRT)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Isometric Resistance Training (IRT)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 197
Study: 32730946

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right posterior parietal cortex (1 mA, 20 min)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right posterior parietal cortex
Number of subjects: 19
Study: 34215557

Group type: EXPERIMENTAL
Intervention: SYNTAX score assessment by 6 clinicians
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intra-observer reliability of risk classification scores
Number of subjects: 50
Study: 33904792

Group type: EXPERIMENTAL
Intervention: Laser acupuncture (LA) plus conventional treatment
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham control (LA without laser output plus conventional treatment)
Number of subjects: 59
Study: 35971655

Group type: EXPERIMENTAL
Intervention: galcanezumab-120 mg
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: galcanezumab-240 mg
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: previous-galcanezumab-120 mg
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: previous-galcanezumab-240 mg
Number of subjects: 1113

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: galcanezumab groups
Number of subjects: 1113
Study: 34851211

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (30 sessions of home-based virtual reality rehabilitation system training, 5 sessions per week, each lasting 45 minutes)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (30 sessions of conventional treatment, 5 sessions per week)
Number of subjects: 70
Study: 32909675

Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 36081429

Group type: EXPERIMENTAL
Intervention: Quantitative nursing and psychological interventions
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 98
Study: 34511499

Group type: EXPERIMENTAL
Intervention: Home-based physical activity program with goal-setting and mentor support
Number of subjects: 52

Group type: COMPARATOR
Intervention: Home-based physical activity program with education and peer contact
Number of subjects: 52
Study: 35417301

Group type: EXPERIMENTAL
Intervention: 2 doses of E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: 3 doses of E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979
Study: 33807782

Group type: EXPERIMENTAL
Intervention: Ergonomics climate assessment at Besat power plant
Number of subjects: 219

Group type: COMPARATOR
Intervention: Ergonomics climate assessment at Rey power plant
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Overall ergonomics climate score
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Overall ergonomics climate score and some subscales
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Ergonomics climate score in employees with musculoskeletal pain
Number of subjects: 219
Study: 32712034

Group type: EXPERIMENTAL
Intervention: Trigger Point Injections (TPIs) with 1% lidocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard conventional approach)
Number of subjects: 0